Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence

doi:10.3748/wjg.v26.i6.670

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7667)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-10) series.

Item

Count

PDF

359

WORD

143

HTML

4294

Figures (1-5)

318

Tables (1-10)

244

Sum=5358

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

921

Download

1388

Sum=2309

Feb 14, 2020 (publication date) through Sep 1, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Feb 14, 2020; 26(6): 670-685
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.670

Full Size Figure Download Figure

Figure 4 Three-year survival of esophageal carcinoma patients. A: The 3-year overall survival rate of patients; B: Survival of the high and low miR-1304 expression groups.

Citation: Luo YG, Duan LW, Ji X, Jia WY, Liu Y, Sun ML, Liu GM. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence. World J Gastroenterol 2020; 26(6): 670-685
URL: https://www.wjgnet.com/1007-9327/full/v26/i6/670.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i6.670